findmyKOL

David Hellmann, MD

Basic profile

Johns Hopkins University

ORCIDNone on fileNPI
RegionBaltimore, MD · NortheastSpecialtyRheumatologyFocusRheumatology/Immunology
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNot yet checkedPaymentsNone reportedNIH funding2010–2010Why? →

David Hellmann is a Rheumatology/Immunology physician affiliated with Johns Hopkins University. OpenAlex indexes 152 publications with 6,919 citations (h-index 40).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
152publications

Distinct works indexed by OpenAlex.

6,919citations

Total citations across indexed works.

40h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1NIH grants · 2010–2010

Federally funded research awards.

View funding

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    48.1%
    Corticosteroid48.1%
    Prednisone100%
    Part D28 patients
  • Cancer & immunology

    35.8%
    Folate Analog Metabolic Inhibitor17.5%
    Methotrexate100%
    Part D<11 patients
    TNF inhibitor11.8%
    Humira Pen56%Humira(Cf) Pen44%
    Part D<11 patients

    + 1 more class in this area

  • Cardiovascular

    16%
    Statin9.9%
    Atorvastatin Calcium100%
    Part D<11 patients
    Calcium channel blocker6.1%
    Amlodipine Besylate100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 20102010 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”